Peer-reviewedLicence not statedNanomedicine
Cuproptosis-based nanomedicine targeting metabolic vulnerabilities for cancer therapy
- 1Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China
- 2Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China
Related
- Nanomedicine-enabled delivery of natural products targeting the Notch cascade: addressing translational barriers in cancer therapy
- A Narrative Review of Nanomedicine in Cancer Therapy: Modulating Metabolic Reprogramming to Enhance Immunotherapy.
- The EPR effect in human tumors: a critical re-evaluation of a nanomedicine dogma and a call for new targeting paradigms
- Polyphosphate Copper Nanospheres Drive Mitochondrial Metabolic Reprogramming via Calcium Phase Separation for Self‐Sensitizing Cuproptosis
- Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy
BibTeX
@article{deng2026cuproptosisbased,
title = {{Cuproptosis-based nanomedicine targeting metabolic vulnerabilities for cancer therapy}},
author = {Jing Deng and Yi Lei and Qin Xia and Yuchen Zhang and Jianping He},
journal = {Nanomedicine},
year = {2026},
month = oct,
doi = {10.1080/17435889.2026.2736188},
url = {https://doi.org/10.1080/17435889.2026.2736188},
}
RIS
TY - JOUR
TI - Cuproptosis-based nanomedicine targeting metabolic vulnerabilities for cancer therapy
AU - Jing Deng
AU - Yi Lei
AU - Qin Xia
AU - Yuchen Zhang
AU - Jianping He
PY - 2026
DA - 2026/10/21
JO - Nanomedicine
DO - 10.1080/17435889.2026.2736188
UR - https://doi.org/10.1080/17435889.2026.2736188
SN - 1743-5889
SN - 1748-6963
ER -